Bristol-Myers Squibb is planning to launch 8 drugs in 18 months for everything from cancer to multiple sclerosis. Here’s what they are and how the $150 billion pharma giant plans to pull it off.

The newly combined Bristol-Myers Squibb and Celgene is shaping up to be a formidable company in the pharmaceutical industry. It’s now looking at eigRead More…

THE DIGITAL HEALTH ECOSYSTEM: The most important players, tech, and trends propelling the digital transformation of the $3.7 trillion healthcare industry (AAPL, IBM, ANTM, GOOGL, MSFT, AMZN, PFE, GE, MCK, TMUS, WMT, WBA, MRK, CVS)

This is a preview of a research report from Business Insider Intelligence, Business Insider’s premium research service. Current subscribers can read Read More…

How to rise the ranks at Point72; a leaked pitch deck reveals WarnerMedia’s aggressive HBO Max strategy; Apple and Amazon could dismantle healthcare as we know it

Finance editor Meredith Mazzilli here, taking the final turn as guest host while executive editor Matt Turner wraps up parental leave. I’ll get tRead More…